Oleuropein: A Potential Inhibitor for Prostate Cancer Cell Motility by Blocking Voltage-Gated Sodium Channels

Hatice Gumushan Aktas1, Huda Ayan1

  • 1Faculty of Arts & Sciences, Biology Department, Harran University, Sanliurfa, Turkey.

Nutrition and Cancer
|August 27, 2020
PubMed

Insights

Olive leaf extract and oleuropein inhibit prostate cancer cell motility by blocking voltage-gated sodium channels (VGSCs). This suggests oleuropein may be a potential antimetastatic agent for prostate cancer.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Cancer Research

Background:

  • Metastasis, a hallmark of cancer, involves cell motility.
  • Voltage-gated sodium channels (VGSCs) are implicated in cancer cell migration.
  • Olive leaf extract (OLE) contains bioactive compounds with potential therapeutic properties.

Purpose of the Study:

  • To investigate the anti-motility effects of OLE and oleuropein on prostate cancer cells.
  • To determine if oleuropein blocks VGSCs and inhibits cell motility.
  • To explore the underlying molecular mechanisms, including SCN9A gene expression.

Main Methods:

  • Preparation and analysis of aqueous extract of olive leaves (AOLE) using LC-MS/MS.
  • Assay of AOLE and oleuropein effects on MAT-LyLu prostate cancer cell motility.
  • Determination of non-toxic concentrations of oleuropein.
  • Analysis of SCN9A mRNA expression using quantitative methods.

Main Results:

  • Oleuropein was identified as the primary active compound in AOLE.
  • Oleuropein significantly suppressed the lateral and vertical movement of MAT-LyLu cells at non-toxic concentrations.
  • Oleuropein reduced SCN9A mRNA expression, indicating VGSC pathway involvement.

Conclusions:

  • Oleuropein effectively inhibits prostate cancer cell motility by targeting VGSCs.
  • Oleuropein's mechanism involves the downregulation of SCN9A mRNA expression.
  • Oleuropein shows promise as a potential antimetastatic agent for prostate cancer treatment.

Related Concept Videos

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
685
Local Anesthetics: Mechanism of Action01:23

Local Anesthetics: Mechanism of Action

Local anesthetics (LAs) block sensory and motor impulses by inhibiting the sodium channels on the nerve cell membranes. This induces temporary loss of sensation, relieving pain in a specific body area.
Local anesthetics are amphiphilic molecules consisting of a hydrophobic aromatic part linked to a hydrophilic group by an ester or amide linkage. They are weak bases and are usually available as salts, which increases their solubility and stability. Once administered, LAs exist in the body either...
2.9K
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
1.3K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
2.5K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.0K
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.5K